Search results for: “biotech”
-
Global Care Capital appoints James Foster to Advisory Board
•
VANCOUVER: Global Care Capital Corp. has announced the appointment of James Foster, a founder of ViraxClear’s joint venture…
-
Moderna and Lonza announce strategic collaboration to manufacture vaccine against Novel Coronavirus
•
BASEL, SWITZERLAND: Moderna Inc., a clinical stage biotechnology company, and Lonza Ltd. have announced a 10-year strategic collaboration…
-
Carlos de Sousa appointed CEO of Ultimovacs ASA
•
OSLO: Ultimovacs ASA, a pharmaceutical company developing novel immunotherapies against cancer, announces that Carlos de Sousa, MD, has…
-
Anthem launches two products to the Indian market
•
LONDON: OptiBiotix Health plc has announced the commercial launch of two products formulated with SlimBiome to the Indian…
-
Cellmid’s Advangen signs trading agreement with Priceline
•
SYDNEY: Cellmid Limited’s wholly owned subsidiary, Advangen International Pty Ltd has entered into a national trading agreement with…
-
Avacta signs collaboration and option agreement with ADC Therapeutics
•
LONDON: Avacta Group plc, a biotechnology company developing novel cancer immunotherapies based on its proprietary Affimer platform, has…
-
LCT to benefit from Semma Therapeutics acquisition by Vertex
•
AUCKLAND: Living Cells Technologies (LCT) holds 121,995 shares in Semma Therapeutics, worth an anticipated USD 838,105 which would…
-
Sumitomo Dainippon Pharma and Roivant Sciences to form strategic alliance
•
TOKYO: Sumitomo Dainippon Pharma has entered into a Memorandum of Understanding for a strategic alliance with Roivant Sciences…
-
IMI to acquire specialty valve manufacturer PBM for $85mn
•
LONDON: IMI plc has announced the proposed acquisition of PBM Inc., for an enterprise value of $85 million.…
-
Thomas McLain appointed President and Chief Commercial Officer of Renalytix AI
•
LONDON, UK: Renalytix AI plc, a developer of artificial intelligence-enabled diagnostics for kidney disease, announced the expansion of…
-
Lonza expands Bioconjugation facility and announces approval of third commercial ADC
•
BASEL, SWITZERLAND: Lonza has announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.